Home Epidemiology and MS

The first epidemiological studies on multiple sclerosis (MS) around the world pictured a north to south latitudinal gradient. Thus, the north of Europe, north of the USA and Canada were considered high risk areas, while Australia, south of Europe and south of the USA had a medium risk and finally Africa, Asia and central-south America's risk was apparently low. This characteristic distribution led to the first genetic and environmental pathogenic hypothesis.

 

MS incidence seems to be increasing during the past 20 years based on recent data from prospective studies performed in Europe, America and Asia; specially in women (increased sex ratio). Furthermore, ther are regions that don't seem to fit in the classical gradient, such as Europe, where a similar the MS prevalence in Sardinia  (southern Europe) is comparable to Norway.

 

At present, the study of the epidemiology of MS is a challenge and a great opportunity to determine if there is an increase and a change in the distribution of the disease or if this conclusions are an artifact of the improved diagnostic techniques and the fact that certain areas with previously unknown MS epidemiological data are begining to be studied.

 

Epidemiology


Highlights

There are no translations available.

Desde el pasado 20 de marzo el Registro EPIDEMCAT permite introducir pacientes prevalentes, es decir, aquellos con inicio de los síntomas antes de 2009 para las formas en brotes y antes del 2006 para las fomas de inicio progresivo. De esta forma, el Registro será completo, permitiendo conocer el impacto global de la enfermedad en Catalunya. Para facilitar la identificación de los pacientes, se ha sustituído la calve identificativa DNI por el CIP.

More news
 
There are no translations available.

El pasado mes de octubre de 2012 se celebró una reunión de trabajo con los participantes en el Registro con una doble finalidad: dar a conocer los datos trascurridos 3 años de funcionamiento y explorar opciones de mejora y expansión del registro. Para más información consultar acta reunión.

More news
 

By january 2012, The MS Registry of Catalonia includes over 600 patients.

More news
 

An European Registry of MS (EUReMS) is starting. The European Multiple Sclerosis Platform (EMSP) is coordinating the project EUReMS, carried out by a multidisciplinary team and funded from the European Commission. The CEM-Cat has been selected by the European Multiple Sclerosis Platform as one of the centers participating in the project. Learn more.

More news